Suspicious scars: physical child abuse vs Ehlers-Danlos syndrome

Por Amal Nishantha Vadysinghe, Chatula Usari Wickramashinghe, Dineshi Nadira Nanayakkara, Chandishni Ishara Kaluarachchi
Publicado no Autopsy and Case Reports (2018)

Suspicious scars: physical child abuse vs Ehlers-Danlos syndrome

Por Vadysinghe, Amal Nishantha, Wickramashinghe, Chatula Usari, Nanayakkara, Dineshi Nadira, Kaluarachchi, Chandishni Ishara
Publicado no Autops Case Rep (2018)

Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer

Por Nishio, Makoto, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Solomon, Benjamin J., Shaw, Alice T., Hashigaki, Satoshi, Ohki, Emiko, Usari, Tiziana, Paolini, Jolanda, Polli, Anna, Wilner, Keith D., Mok, Tony
Publicado no Cancer Res Treat (2018)

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)

Por Groen, H. J. M., Socinski, M. A., Grossi, F., Juhasz, E., Gridelli, C., Baas, P., Butts, C. A., Chmielowska, E., Usari, T., Selaru, P., Harmon, C., Williams, J. A., Gao, F., Tye, L., Chao, R. C., Blumenschein, G. R.
Publicado no Ann Oncol (2013)

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001

Por Shaw, A T, Riely, G J, Bang, Y -J, Kim, D -W, Camidge, D R, Solomon, B J, Varella-Garcia, M, Iafrate, A J, Shapiro, G I, Usari, T, Wang, S C, Wilner, K D, Clark, J W, Ou, S -H I
Publicado no Ann Oncol (2019)